NASDAQ:HUMAW
Humacyte, Inc.
- Stock
Last Close
6.47
16/05 20:00
Market Cap
301.40M
Beta: -
Volume Today
4.32M
Avg: -
PE Ratio
−3.64
PFCF: −4.65
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
asset turnover | ||||||
cash per share | 0.39 - | 5.64 1,355.38% | 1.47 73.88% | 0.78 47.22% | ||
company equity multiplier | -0.30 - | 2.35 870.09% | 1.75 25.50% | 9.47 441.75% | ||
days of inventory outstanding | ||||||
days of payables outstanding | 15.60K - | |||||
days of sales outstanding | ||||||
dividend yield | ||||||
ebit per revenue | -13.85 - | |||||
ebt per ebit | 1.03 - | 0.33 68.34% | 0.14 56.61% | 1.11 682.68% | ||
effective tax rate | -0.03 - | 2.42 7,403.99% | 6.37 163.36% | |||
enterprise value multiple | -18.52 - | -0.88 95.24% | -0.72 18.34% | -2.29 218.74% | ||
fixed asset turnover | ||||||
free cash flow per share | -27.67 - | -0.54 98.04% | -2.04 275.39% | -0.70 65.61% | ||
gross profit margin | 1 - | |||||
interest coverage | -37.29 - | -29.34 21.33% | -18.68 36.34% | -13.64 26.96% | ||
inventory turnover | ||||||
long term debt to capitalization | -0.08 - | 0.28 475.45% | 0.25 11.62% | |||
net income per ebt | 1.03 - | -1.42 237.23% | -5.37 278.59% | 1 118.63% | ||
net profit margin | ||||||
operating cash flow per share | -24.85 - | -0.54 97.83% | -2.03 276.52% | -0.69 66.02% | ||
operating profit margin | -13.85 - | |||||
payables turnover | 0.02 - | |||||
pretax profit margin | ||||||
price fair value | -2.99 - | 2.37 179.32% | 1.86 21.60% | 21.68 1,065.99% | ||
receivables turnover | ||||||
return on assets | -0.64 - | 0.13 120.34% | 0.31 139.95% | -0.86 374.85% | ||
return on capital employed | -0.68 - | -0.29 56.44% | -0.46 55.32% | -0.91 99.04% | ||
return on equity | 0.20 - | 0.31 56.61% | 0.55 78.76% | -8.18 1,588.98% | ||
total debt to capitalization | -0.09 - | 0.29 425.72% | 0.29 0.83% |
All numbers in USD (except ratios and percentages)